Are there clinical and laboratory predictors of 5-year mortality in HIV-infected children and adolescents with hemophilia?

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 4, 1998, Pages 349-357

  Hoots, W Keith ^a   Mahoney, Elizabeth ^b   Donfield, Sharyne ^c   Bale, James ^d   Stehbens, James ^e   Maeder, Margaret ^b   Loveland, Katherine ^f   Contant, Charles ^g  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c RHO INC   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f University of Texas Mental Sciences Institute   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adolescents; AIDS; Children; Hemophilia; Predictors of mortality

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ADOLESCENT; AGE FACTORS; ATROPHY; BODY HEIGHT; BRAIN; CD4 LYMPHOCYTE COUNT; CHILD; COHORT STUDIES; ERYTHROCYTE INDICES; HEMATOPOIESIS; HEMOGLOBINS; HEMOPHILIA A; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MUSCULAR ATROPHY; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032146185     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199808010-00006     Document Type: Article

References (52)

1. Whittle H, Egboga A, Todd J, et al. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. AIDS 1992;6:685-9.
2. Bacchetti P, Moss AR, Andrews JC, Jacobson MA. Early predictors of survival in symptomatic HIV-infected persons treated with high-dose zidovudine. J Acquir Immune Defic Syndr 1992;5: 732-6.
3. + lymphocyte count <50/μl. J Infect Dis 1995;171:829-36.
4. Luo K, Law M, McDonald A, Kaldor J. Predictors for survival following AIDS in Australia: The National HIV Surveillance Committee [abstract #010C]. Presented at the X International Conference on AIDS, Yokahama, Japan, 1994.
5. Brackin MN, Lewis RE, Brackin BT, et al. Progression of HIV infection is associated with HLA-DQ antigens in Caucasians and African Americans. Pathobiology 1995;63:22-41.
6. Montoro JB, Oliveras J, Lorenzo JI, et al. An association between clotting factor concentrates use and mortality in human immunodeficiency virus-infected hemophilic patients. Blood 1995;86: 2213-9.
7. Ehmann WC, Eyster ME, Wilson SE, Andes WA, Goedert JJ. Relationship of CD4 lymphocyte counts to survival in a cohort of hemophiliacs infected with HIV. Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1994;7:1095-8.
8. Lee C, Sabin C, Phillips A, Elford J, Griffiths P, Janossy G. Twelve year follow-up of a haemophilic cohort [abstract MoC 0062]. Presented at the VIII International Conference on AIDS, Amsterdam, The Netherlands, July 1992.
9. Vicariot M, Fressinaud E, Fiks M, et al. Infection VIH chez les hemophiles A et B (HIV infection among Type A and B hemophiliacs) (Original in French). Rev Fr Transfusion Hemobiol 1993; 36:417-26.
10. Butler KM, Husson RN, Lewis LL, Mueller BU, Venzon D, Pizzo PA. CD4 status and p24 antigenemia. Are they useful predictors of survival in HIV-infected children receiving antiretroviral therapy? Am J Dis Child 1992;146:932-6.
11. McKinney RE Jr, Wilfert C. Growth as a prognostic indicator in children with human immunodeficiency virus infection treated with zidovudine. AIDS Clinical Trials Group Protocol 043 Study Group. J Pediatr 1994;125:728-33.
12. Jackson CR, Vavro CL, St Clair MH, Valentine ME, McKinney RE. Long-term survival in pediatric HIV patients [abstract #161]. Presented at the II National Conference on Human Retroviruses and Related Infections, Washington, DC, January 1995.
13. Papaevangelou V, Pollack H, Kaul A, Lawrence R, Krasinski K, Borkowsky W. HIV-1 infected children with severe immunodeficiency: survival and prognostic factors [abstract #35]. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 1994.
14. Pizzo PA, Wilfert CM. Markers and determinants of disease progression in children with HIV infection. The Pediatric AIDS Siena Workshop II. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:30-44.
15. Belman AL. Neurologic syndromes associated with symptomatic human immunodeficiency virus infection in infants and children. In Koslowski PB, Snider DA, Vietze PM, Wisniewski HM, eds. Brain in Pediatric AIDS. New York: Karger, 1990:45-63.
16. Loveland KA, Stehbens JA. Early neurodevelopmental signs of HIV infection in children and adolescents; In Kozlowski PB, Snyder DA, Vietze PM, Wisniewski HM, eds. Brain in Pediatric AIDS. New York: Karger, 1990:64-71.
17. Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of human immunodeficiency virus 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989;321: 1141-8.
18. Scott GB, Brick BE, Letterman JG, Bloom FI, Parks NP. Acquired immunodeficiency syndrome in infants. N Engl J Med 1984;310: 76-81.
19. Jason J, Gomperts E, Lawrence DN, et al. HIV and hemophilic children's growth. J Acquir Immune Defic Syndr 1989;2:277-82.
20. Brettler DB, Forsberg A, Bolivar E, Brewster F, Sullivan J. Growth failure as a prognostic indicator for progression to acquired immunodeficiency syndrome in children with hemophilia. J Pediatr 1990;117:584-4.
21. Hilgartner MW, Donfield SM, Willoughby A, et al. Hemophilia growth and development study. Design, methods, and entry data. Am J Pediatr Hematol Oncol 1993;15:208-18.
22. Mahoney E, Orav EJ. A missing data approach to parameter estimation in multi-stage disease models for doubly-censored failure times. Unpublished doctoral thesis, Cambridge, MA: Harvard University, 1993.
23. Leavitt M. GrowthBased+. Beaverton, Oregon: Medical Logic, 1991.
24. Centers for Disease Control and Prevention. Anthro, Version 1.01. Atlanta, GA: Division of Nutrition, Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 1990.
25. Bale JF, Contant CF, Garg B, Tilton A, Kaufman D, Wasiewski W. Neurologic history and examination results and their relationship to human immunodeficiency virus type 1 serostatus in hemophilic subjects: results from the hemophilia growth and development study. Pediatrics 1993;91(4):736-41.
26. Sparrow S, Balla D, Cicchetti D. Vineland adaptive behavior scales, interview edition. Circle Pines, MN: American Guidance Service, 1984.
27. Lindgren SD, Koeppl GK. Assessing child behavior problems in a medical setting: development of the pediatric behavior scale. In Prinz R, ed. Advances in behavioral assessment of children and families. Greenwich, CT: JAI, 1987:3, 57-90.
28. Holzman RS, Walsh CM, Kaspatkins S. Risk for the acquired immunodeficiency syndrome among thrombocytopenic and non-thrombocytopenic homosexual men seropositive for the human immunodeficiency virus. Ann Intern Med 1987;106:383-6.
29. Eyster ME, Gsil MH, Ballard JO, Al-Mondhiry H, Goedert JJ. Natural history of human immunodeficiency virus infection in hemophiliacs: effects of T-cell subsets platelet counts, and age. Ann Intern Med 1957;107:1-6.
30. Ragni MV, Bontempo FA, Myers DJ, Kiss JE, Oral A. Hemorrhagic sequelae of immune thrombocytopenic purpura in human immunodeficiency virus - infected hemophiliacs. Blood 1990;75: 1267-72
31. Miller CH, Levy ND. Effects of storage conditions on lymphocyte phenotypes from healthy and diseased persons. J Clin Lab Anat 1989;3:296-300.
32. Nicholson JK, Jones BM. Lymphocyte immunophenotyping at the Centers for Disease Control: the program and special studies. Clin Immunol Immunopathol 1988;52:61-7.
33. Parker JW, Adelsberg B, Azen SP, et al. Leukocyte immunophenotyping by flow cytometry in a multisite study: standardization, quality control, and normal values in the transfusion safety study. Clin Immunol Immunopathol 1990;55:187-220.
34. Corriel RN, Kniker WT, McBride JL, Lesourd BM. Cell-mediated immunity in school children assessed by multitest skin testing. Am J Dis Child 1985;139:141-6.
35. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1985;53:457-81.
36. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972;34:187-220.
37. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987;36:1-15S.
38. Centers for Disease Control. Revised classification system for human immunodeficiency virus in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43:1-19.
39. Gertner JM, Kaufman FR, Donfield SM, et al. Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: hemophilia growth and development study. J Pediatr 1994;124:896-902.
40. Mitchell WG, Nelson MD, Contant CF, et al. Effects of human immunodeficiency virus and immune status on magnetic resonance imaging of the brain in hemophilic subjects: results from the hemophilia growth and development study. Pediatrics 1993;91: 742-6.
41. Loveland KA, Stehbens J, Contant C, et al. Hemophilia growth and development study: baseline neurodevelopmental findings. J Pediatr Psychol 1994;19:223-39.
42. O'Brien TR, Blattner WA, Waters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the multicenter hemophilia cohort study. JAMA 1996;276:105-10.
43. Major C, Li X, Strunc G, et al. HIV-1 viral load in progressors vs non-progressors. Proceedings of III Conference on Retroviruses and Opportunistic Infections. Washington, DC: Infectious Disease Society of America, 1996:101.
44. Ioannidis JP, Cappelleri JC, Lau J, Sacks HS, Skolnik PR. Predictive value of viral load measurements in asymptomatic untreated HIV-1 infection: a mathematical model. AIDS 1996;10:255-62.
45. Schooley RT. Correlation between viral load measurements and outcome in clinical trials of antiviral drugs. AIDS 1995;9(Suppl 2):S15-19.
46. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
47. Pollack H, Glasberg H, Lee E, et al. Impaired early growth of infants perinatally infected with human immunodeficiency virus: correlation with viral load. J Pediatr 1997;130:915-22.
48. Falloon I, Eddy J, Weiner L, Pizzo PA. Human immunodeficiency virus infection in children. J Pediatr 1989;114:1-30.
49. Pahwa S. Human immunodeficiency virus infection in children: nature of immunodeficiency, clinical spectrum and management. Pediatr Infect Dis J 1988;7:S61-71.
50. Laue L, Pizzo PA, Butler K, et al. Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome. J Pediatr 1990;117:541-5.
51. Dean M, Carrington M, Winkler C, et al., and the Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
52. Perelson AS, Essunger P, Markowitz M, Ho DD. Viral and cellular dynamics: implications for antiretroviral therapy [abstract #60]. Presented at the IV Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 22-26, 1997.